ADDIS ABABA – A total of 32 patients have lost their lives in Ethiopia due to Covid-19 related health complications in the past 48 hours, data from the ministry of health shows.
The ministry confirms the death of 12 people on Saturday and 20 others on Sunday.
To date, 3,996 people have died due to the virus that causes the respiratory disease, according to the ministry.
Ethiopia confirmed its first coronavirus disease (COVID-19) related death on April 15, 2020.
Drop in hospitalization
The ministry has also registered a combined 851 new cases of COVID-19 for Saturday and Sunday, bringing the tally of confirmed cases to over 266, 000.
Nearly 800 medical tests have been conducted to identify the new positive cases.
Data from the ministry indicates the rate of hospitalizations has continued to drop for eight consecutive days.
Some 582 severely sick patients are currently getting treatment in medical facilities, the ministry’s Covid-19 report for Sunday shows.
The patients are among the 42, 700 active cases in the country.
The ministry also reported the recovery of 1, 496 Covid-19 patients on Saturday while 700 more recuperated on Sunday.
To date, 219, 566 people have recovered after contracting coronavirus in the country.
The East Africa Nation has so far conducted more than 2.65mln medical tests and confirmed 266, 264 Covid-19 cases, reported its ministry of health
– AstraZeneca Dominates –
On the same, the ministry said the government is working to increase access to vaccination in all regions.
As of Sunday evening, they have administered COVID-19 vaccine to 1.46mln people since they started the vaccination campaign in mid-March.
It took them up to 20 days to reach all target areas with the vaccine through the existing 6,000 healthcare stations situated in 20,000 localities in more than 1,000 Woredas of the country.
Over 1 Million of the vaccine doses administered are AstraZeneca vaccines, according the ministry.
The country received its first batch of 2.2 million doses of this vaccine from the World Health Organization-led COVAX facility in March, 2021